(function(){var loadHandler=window['sl_{EC00A760-FAC2-48CD-8603-FA3C7FB92E6B}'];loadHandler&&loadHandler(14, '<div id="spr0_3653e6d"><div id="spr1_3653e6d" class="kern slide"><img id="img0_3653e6d" src="data/img9.png" width="1280px" height="720px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_3653e6d" class="kern slide"><div id="spr3_3653e6d" style="left:88px;top:38.333px;"><div style="width:0px;"><span id="txt0_3653e6d" data-width="385.572937" style="left:9.6px;top:24.307px;">Common pitfalls</span></div></div><div id="spr4_3653e6d" style="left:88px;top:191.667px;"><div style="width:0px;"><span id="txt1_3653e6d" class="nokern relpos" dir="auto" style="left:9.6px;top:2.376px;">•</span> <span id="txt2_3653e6d" class="relpos" data-width="829.518188" style="left:24.264px;top:-1.38px;">Determination of clinically-relevant and population-specific genetic markers;</span></div><div style="width:0px;"><span id="txt3_3653e6d" class="nokern relpos" dir="auto" style="left:9.6px;top:43.74px;">•</span> <span id="txt4_3653e6d" class="relpos" data-width="1016.796875" style="left:24.264px;top:39.984px;">Identification of genetic variants linked to specific diseases and/or genetic variants correlating</span></div><div style="width:0px;"><span id="txt5_3653e6d" data-width="305.833313" style="left:33.6px;top:69.553px;">with response to treatment;</span></div><div style="width:0px;"><span id="txt6_3653e6d" class="nokern relpos" dir="auto" style="left:9.6px;top:114.673px;">•</span> <span id="txt7_3653e6d" class="relpos" data-width="1008.138000" style="left:24.264px;top:110.917px;">Hesitance to analyse large molecule sets (i.e., analysis of proteins, lipids, metabolites, etc.) as</span></div><div style="width:0px;"><span id="txt8_3653e6d" data-width="129.817703" style="left:33.6px;top:140.486px;">biomarkers;</span></div><div style="width:0px;"><span id="txt9_3653e6d" class="nokern relpos" dir="auto" style="left:9.6px;top:185.607px;">•</span> <span id="txt10_3653e6d" class="relpos" data-width="660.937500" style="left:24.264px;top:181.85px;">Identification and stratification of the eligible patient groups;</span></div><div style="width:0px;"><span id="txt11_3653e6d" class="nokern relpos" dir="auto" style="left:9.6px;top:227.74px;">•</span> <span id="txt12_3653e6d" class="relpos" data-width="1045.611938" style="left:24.264px;top:223.984px;">Adoption and establishment of solid regulatory measures that encourage innovation and patient</span></div><div style="width:0px;"><span id="txt13_3653e6d" data-width="72.747391" style="left:33.6px;top:253.553px;">safety;</span></div><div style="width:0px;"><span id="txt14_3653e6d" class="nokern relpos" dir="auto" style="left:9.6px;top:298.673px;">•</span> <span id="txt15_3653e6d" class="relpos" data-width="608.411438" style="left:24.264px;top:294.917px;">Reliability and consistency of the biomarker test quality;</span></div><div style="width:0px;"><span id="txt16_3653e6d" class="nokern relpos" dir="auto" style="left:9.6px;top:340.807px;">•</span> <span id="txt17_3653e6d" class="relpos" data-width="355.351563" style="left:24.264px;top:337.05px;">Timely availability of test results;</span></div><div style="width:0px;"><span id="txt18_3653e6d" class="nokern relpos" dir="auto" style="left:9.6px;top:382.94px;">•</span> <span id="txt19_3653e6d" class="relpos" data-width="502.890625" style="left:24.264px;top:379.184px;">Reimbursement options in different countries.</span></div></div><div id="spr5_3653e6d" style="left:697.5px;top:535.819px;"><div style="width:0px;"><span id="txt20_3653e6d" data-width="43.937500" style="left:9.6px;top:5.158px;">Alyass</span></div><div style="width:0px;"><span id="txt21_3653e6d" data-width="32.179688" style="left:56.267px;top:5.158px;">et al.</span></div><div style="width:0px;"><span id="txt22_3653e6d" class="relpos" data-width="135.130310" style="left:91.933px;top:5.158px;">BMC Med Genomics</span> <span id="txt23_3653e6d" class="relpos" data-width="80.539063" style="left:91.927px;top:5.158px;">. 2015;8:33.</span></div><div style="width:0px;"><span id="txt24_3653e6d" data-width="44.812500" style="left:13.6px;top:24.358px;">Joyner</span></div><div style="width:0px;"><span id="txt25_3653e6d" data-width="25.617188" style="left:61.7px;top:24.358px;">and</span></div><div style="width:0px;"><span id="txt26_3653e6d" data-width="47.875000" style="left:90.867px;top:24.358px;">Paneth</span></div><div style="width:0px;"><span id="txt27_3653e6d" style="left:138.553px;top:24.358px;">.</span></div><div style="width:0px;"><span id="txt28_3653e6d" class="relpos" data-width="298.656250" style="left:145.387px;top:24.358px;">Seven questions for personalized medicine. </span> <span id="txt29_3653e6d" class="relpos" data-width="41.622501" style="left:145.38px;top:24.358px;">JAMA</span> <span id="txt30_3653e6d" class="relpos" style="left:145.373px;top:24.358px;">.</span></div><div style="width:0px;"><span id="txt31_3653e6d" data-width="141.062500" style="left:9.6px;top:43.558px;">2015;314:999-1000.</span></div><div style="width:0px;"><span id="txt32_3653e6d" data-width="69.578125" style="left:9.6px;top:62.758px;">Parkinson</span></div><div style="width:0px;"><span id="txt33_3653e6d" data-width="32.179688" style="left:82.54px;top:62.758px;">et al.</span></div><div style="width:0px;"><span id="txt34_3653e6d" data-width="425.164063" style="left:118.207px;top:62.758px;">Making personalized cancer medicine a reality: challenges and</span></div><div style="width:0px;"><span id="txt35_3653e6d" data-width="437.835938" style="left:9.6px;top:81.958px;">opportunities in the development of biomarkers and companion</span></div><div style="width:0px;"><span id="txt36_3653e6d" class="relpos" data-width="83.929688" style="left:9.6px;top:101.158px;">diagnostics. </span> <span id="txt37_3653e6d" class="relpos" data-width="107.450630" style="left:9.593px;top:101.158px;">Clin Cancer Res</span> <span id="txt38_3653e6d" class="relpos" data-width="130.148438" style="left:9.587px;top:101.158px;">. 2012;18:619-624.</span></div><div style="width:0px;"><span id="txt39_3653e6d" data-width="45.867188" style="left:13.1px;top:120.358px;">Reavie</span></div><div style="width:0px;"><span id="txt40_3653e6d" style="left:58.5px;top:120.358px;">.</span></div><div style="width:0px;"><span id="txt41_3653e6d" data-width="479.234375" style="left:65.333px;top:120.358px;">Four important considerations for the successful development of an in</span></div><div style="width:0px;"><span id="txt42_3653e6d" class="relpos" data-width="241.164063" style="left:9.6px;top:139.558px;">vitro or companion diagnostic test. </span> <span id="txt43_3653e6d" class="relpos" data-width="70.005318" style="left:9.593px;top:139.558px;">Published</span> <span id="txt44_3653e6d" class="relpos" data-width="117.507813" style="left:9.587px;top:139.558px;"> November 2018.</span></div></div></div></div>', '{"s":[]}');})();